Biotricity to present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th
REDWOOD CITY, Calif., May 23, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity issues shareholder update
REDWOOD CITY, Calif., May 05, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity to launch commercial sales of its disruptive cardiac monitoring device, Biotres in April 2022
REDWOOD CITY, Calif., Mar 22, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity named to Fast Company’s annual list of the World’s 50 Most Innovative Companies for 2022
REDWOOD CITY, Calif., Mar 08, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity, Inc. to attend 34th annual Roth Conference March 13th-15th
REDWOOD CITY, Calif., Mar 04, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity now taking pre-orders for its Biotres wireless wearable cardiac monitoring device
REDWOOD CITY, Calif., Feb 23, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity releases Fiscal 2022 third quarter financial results
REDWOOD CITY, Calif., Feb 14, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity to report third quarter fiscal 2022 financial results on February 14, 2022
REDWOOD CITY, Calif., Feb 08, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity receives FDA 510(k) clearance for its Biotres Cardiac Monitoring Device
REDWOOD CITY, Calif., Jan 24, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity expands distribution of new Bioheart device on Amazon.com
REDWOOD CITY, Calif., Dec 28, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a modern medical technology company delivering innovative, remote biometric monitoring solutions,…
Biotricity completes $12 million non-dilutive debt financing
REDWOOD CITY, Calif., Dec 27, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a modern medical technology company delivering innovative, remote biometric monitoring solutions,…
Biotricity, a leader in remote cardiac health monitoring solutions, issues company roadmap in 2021 shareholder letter
REDWOOD CITY, Calif., Dec 07, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company,…